Author

Sophie Fougeray

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Catherine GratasiD· 2 shared Claire PecqueuriD· 2 shared Elodie GuietiD· 2 shared François ParisiD· 2 shared Jocelyn OllieriD· 2 shared Marine DevinatiD· 2 shared Pauline ThomasiD· 2 shared Pierre ParisiD· 2 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Catherine GratasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 21, 2026

Functional diversity of Vγ9Vδ2 T cells overcomes glioblastoma state plasticity and antigen heterogeneity

Pierre Paris, Marine Devinat, Julianne Ceroni…·Claire Pecqueur

This study shows that combining GD2/OAcGD2-specific CAR and unmodified Vγ9Vδ2 T cells can overcome glioblastoma heterogeneity by targeting both PN and MES tumor states.

DOI 10.64898/2026.05.19.726243

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 17, 2023

Targeting pediatric High-Grade Gliomas with OAcGD2-CAR Vδ2 T cells

Pauline Thomas, Maëva Veerasamy, Marine Devinat…·Sophie Fougeray

This study evaluates OAcGD2-CAR T cell immunotherapy for pediatric high-grade gliomas, showing Vδ2 T cells outperform conventional β T cells in eliminating tumor cells.

DOI 10.1101/2023.11.17.567375

humanproteomics

𝕏 PostBluesky